Diabetes drugs and T2DM management - Statistics

General Stats

Answer Stats

Hint	Answer	% Correct
biguanide	metformin	100%
SGLT-2 inhibitor	empagliflozin	67%
SGLT-2 inhibitor	dapagliflozin	56%
sulphonylurea	gliclazide	56%
GLP-1 agonist	liraglutide	56%
thiazolidinedione	pioglitazone	56%
DPP-4 inhibitor	sitagliptin	56%
SGLT-2 inhibitor	canagliflozin	44%
GLP-1 agonist	exenatide	33%
HbA1C target: no glucose altering meds	48	22%
HbA1C target: glucose altering meds	53	22%
DPP-4 inhibitor	alogliptin	22%
GLP-1 agonist	dulaglutide	22%
2nd line: high BMI - cause weight loss	glp-1 agonist	22%
DPP-4 inhibitor	linagliptin	22%
1st line: QRISK<10%	1 metformin	11%
3rd line	add 3rd drug or insulin	11%
2nd line: weight neutral - no effect on weight	dpp-4 inhibitor	11%
Drugs causing renal impairment	metformin, sulphonylurea	11%
4th line: insulin currently or 5th line	specialist	11%
2nd line: normal BMI - meds cause weight gain	sulphonylurea, pioglitazone	11%
4th line: no insulin currently	swap for glp-1 agonist	11%
at any point: QRISK>10%	add sglt-2 inhibitor	0%
Drugs offering cardio benefits	sglt-2 inhibitor, glp-1 agonist	0%

Score Distribution

Percent of People with Each Score

Percentile by Number Answered

Your Score History

You have not taken this quiz